Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
Besu F TeshomeScott Martin VouriNicholas HamptonMarin H KollefScott T MicekPublished in: Pharmacotherapy (2019)
Among critically ill patients who receive antipseudomonal β-lactam antibiotics, each additional day of exposure to cefepime, meropenem, and piperacillin-tazobactam is associated with an increased risk of new resistance development.
Keyphrases